Repeated renal failure with use of captopril in a cystinotic renal allograft recipient.
نویسندگان
چکیده
منابع مشابه
Tophaceous gout in a renal allograft recipient
A 65-year-old female received a renal transplantation 3 years ago, and her maintenance immunosuppressive regimen included prednisolone 5 mg once daily (0.1 mg/kg/ day), mycophenolate mofetil 1 g twice daily and cyclosporin 125 mg twice daily (5 mg/kg/day) with average trough serum levels of cyclosporine between 200 and 300 ng/mL since 3 months after renal transplantation. Her first episode of g...
متن کاملAdefovir nephrotoxicity in a renal allograft recipient
Adefovir dipivoxil, an oral prodrug of adefovir, is used in the treatment of lamivudine-resistant hepatitis B virus (HBV) infection. Nephrotoxicity manifesting as proximal renal tubular dysfunction and acute tubular necrosis (ATN) were commonly reported in the past, when higher doses were used for the treatment of human immunodeficiency virus infection. However, nephrotoxicity is rare at lower ...
متن کاملUnusual manifestation of cutaneous Leishmaniasis in a renal transplant recipient
Cutaneous leishmaniasis may present as unusual manifestations in renal transplant patients receiving immunosuppressive therapy. This misleading presentation, may delay the diagnosis and treatment. Moreover special caution must be taken in renal transplant recipients because of possible interactions between antimony compounds and cyclosporine metabolites. We report a 45-year old man with 5 years...
متن کاملTuberculosis in a renal allograft recipient presenting with intussusception
Extra-pulmonary tuberculosis (TB) is more common in renal allograft recipients and may present with dissemination or an atypical features. We report a renal allograft recipient with intestinal TB presenting 3 years after transplantation with persistent fever, weight loss, diarrhea, abdominal pain and mass in the abdomen with intestinal obstruction. He was diagnosed to be having an ileocolic int...
متن کاملTreatment of acute myeloid leukaemia in a renal allograft recipient
cyclosporin may not greatly increase the toxicity ofaggressive chemotherapy used in the treatment of haematological malignancies. Sonneveld and Nooter reported a patient with resistent AML to whom they administered cyclosporin without any excessive toxicity, although their patient had profound marrow hypoplasia for three weeks.9 Septic shock is a well recognised problem in severely neutropenic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1982
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.285.6354.1538